RxSight (RXST) Return on Invested Capital (2021 - 2024)

RxSight's Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.09% for Q1 2024.

• Quarterly Return on Invested Capital fell 9.0% year-over-year to 0.09% in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.09% (down 9.0% YoY) and the FY2022 annual result came in at 12.46%, changed N/A from the prior year.
• Return on Invested Capital was 0.09% for Q1 2024 at RxSight, up from 47.91% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.01% in Q4 2022 and bottomed at 47.91% in Q4 2023.
• A 4-year average of 4.36% and a median of 0.01% in 2022 frame the typical range for Return on Invested Capital.
• Annual changes were most pronounced in 2022 — Return on Invested Capital changed 0 bps — and 2023, when it tumbled 4792 bps.
• RxSight's Return on Invested Capital stood at 0.01% in 2021, then surged by 44 bps to 0.01% in 2022, then sank by 419917 bps to 47.91% in 2023, then surged by 100 bps to 0.09% in 2024.
• Business Quant data shows RXST's Return on Invested Capital at 0.09% in Q1 2024, 47.91% in Q4 2023, and 0.0% in Q3 2023.